Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GABA analog prodrug sustained release oral dosage forms

GABA analog prodrug sustained release oral dosage forms

US Patent 8906412 · Granted Dec 9, 2014

Estimated economic value: $6,038,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic peptides2023
Peptide-containing formulations2022
Combination dosage form of a mu opioid receptor antagonist and an opioid agent2022
Therapeutic peptides2022
Therapeutic peptides2021
Methods of administering monomethyl fumarate and prodrugs thereof having reduced2021
Combination dosage form of a mu opioid receptor antagonist and an opioid agent2021
Combination dosage form of a mu opioid receptor antagonist and an opioid agent2019
GABA analog prodrug sustained release oral dosage forms2018
GABA analog prodrug sustained release oral dosage forms2018
GABA analog prodrug sustained release oral dosage forms2018
GABA analog prodrug sustained release oral dosage forms2018